Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON

The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.

Inclusion Criteria:

• ST-segment elevation AMI within 12 hours of symptom onset

Exclusion Criteria:

• Contraindications to thrombolysis or PCI
• Patients administered a fibrinolytic agent before PCI
• Patients enrolled in clinical trials